JAHA:Fontan相关性肝病:儿童和青少年的疾病谱

2020-01-06 xiangting MedSci原创

在具有Fontan生理学特征的儿科患者队列中,肝病普遍存在。考虑到TE与Fontan存在时间有相关性,TE具有作为肝脏病理前瞻性标志物的潜力。

具有Fontan循环的儿科患者肝病的信息正在不断发展。这项研究目的是评估具有Fontan生理学特征儿科患者的肝病疾病谱,并评估瞬时弹性成像(TE)是否可作为肝病的非侵入性标志物。

研究前瞻性招募了具有Fontan生理学特征的所有儿童。所有患者均接受了全面的肝功能评估,包括肝酶(丙氨酸氨基转移酶、天冬氨酸氨基转移酶、γ-谷氨酰转移酶、碱性磷酸酶)、天冬氨酸转氨酶与血小板的比例指数、白蛋白、胆红素、国际标准化比率、全血细胞计数、腹部超声和TE。在部分患者中进行了经颈静脉肝活检和血液动力学测定。

共评估了76儿童(中位数为11.7;四分位间距为8.4-14.8 [男性占56]),其中17名儿童进行了经颈静脉肝穿刺活检(中位数为14.8岁;四分位间距为14.3-17.4)。所有活检均显示有病理改变。肝脏病变的严重程度与TE不相关。TEFontan循环的时间(R=0.42P<0.01)、天冬氨酸转氨酶与血小板的比例指数(R=0.29P=0.02)、天冬氨酸转氨酶(R=-0.42P<0.01)和血小板(R=-0.42P0.01)呈正相关。腹部超声显示脾肿大与TEz=-2.2P=0.03)、血小板计数低(z=1.9P=0.05)、天冬氨酸转氨酶低(z=1.9P=0.02)和碱性磷酸酶低相关(z=2.4P=0.02) 。

在具有Fontan生理学特征的儿科患者队列中,肝病普遍存在。考虑到TEFontan存在时间有相关性,TE具有作为肝脏病理前瞻性标志物的潜力。但是,TE与病理的严重程度无关。鉴于该人群中肝病的患病率,应采取肝脏健康保护措施和常规的肝脏健康监测,并在肝生化指标或影像学检查异常时考虑进行肝病咨询和活检。

原始出处:

Steven L. Rathgeber. Fontan‐Associated Liver Disease: Spectrum of Disease in Children and Adolescents. JAHA. January 2020.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1937499, encodeId=962a193e499c5, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Fri Dec 11 12:31:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837776, encodeId=afec183e776f8, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Tue Sep 15 10:31:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081833, encodeId=43e820818330b, content=<a href='/topic/show?id=3affe58886' target=_blank style='color:#2F92EE;'>#Fontan相关性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7588, encryptionId=3affe58886, topicName=Fontan相关性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Wed Apr 08 16:31:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699974, encodeId=2b6916999e4fb, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Wed Dec 16 18:31:00 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268231, encodeId=d09e126823103, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jan 08 04:31:00 CST 2020, time=2020-01-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1937499, encodeId=962a193e499c5, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Fri Dec 11 12:31:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837776, encodeId=afec183e776f8, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Tue Sep 15 10:31:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081833, encodeId=43e820818330b, content=<a href='/topic/show?id=3affe58886' target=_blank style='color:#2F92EE;'>#Fontan相关性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7588, encryptionId=3affe58886, topicName=Fontan相关性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Wed Apr 08 16:31:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699974, encodeId=2b6916999e4fb, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Wed Dec 16 18:31:00 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268231, encodeId=d09e126823103, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jan 08 04:31:00 CST 2020, time=2020-01-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1937499, encodeId=962a193e499c5, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Fri Dec 11 12:31:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837776, encodeId=afec183e776f8, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Tue Sep 15 10:31:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081833, encodeId=43e820818330b, content=<a href='/topic/show?id=3affe58886' target=_blank style='color:#2F92EE;'>#Fontan相关性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7588, encryptionId=3affe58886, topicName=Fontan相关性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Wed Apr 08 16:31:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699974, encodeId=2b6916999e4fb, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Wed Dec 16 18:31:00 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268231, encodeId=d09e126823103, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jan 08 04:31:00 CST 2020, time=2020-01-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1937499, encodeId=962a193e499c5, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Fri Dec 11 12:31:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837776, encodeId=afec183e776f8, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Tue Sep 15 10:31:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081833, encodeId=43e820818330b, content=<a href='/topic/show?id=3affe58886' target=_blank style='color:#2F92EE;'>#Fontan相关性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7588, encryptionId=3affe58886, topicName=Fontan相关性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Wed Apr 08 16:31:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699974, encodeId=2b6916999e4fb, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Wed Dec 16 18:31:00 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268231, encodeId=d09e126823103, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jan 08 04:31:00 CST 2020, time=2020-01-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1937499, encodeId=962a193e499c5, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Fri Dec 11 12:31:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837776, encodeId=afec183e776f8, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Tue Sep 15 10:31:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081833, encodeId=43e820818330b, content=<a href='/topic/show?id=3affe58886' target=_blank style='color:#2F92EE;'>#Fontan相关性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7588, encryptionId=3affe58886, topicName=Fontan相关性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Wed Apr 08 16:31:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699974, encodeId=2b6916999e4fb, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Wed Dec 16 18:31:00 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268231, encodeId=d09e126823103, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jan 08 04:31:00 CST 2020, time=2020-01-08, status=1, ipAttribution=)]
    2020-01-08 zhaohui6731